364 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
Long-term portion of financial royalty assets, net
Property and equipment, net
Operating lease right-of-use assets
Financing lease right-of-use assets … lease liabilities
Current deferred revenue
Total current liabilities
Long-term contingent liabilities
Long-term operating lease liabilities
Deferred
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
lease liabilities
Deferred revenue
2023 convertible senior notes, net
Total current liabilities
Long-term contingent liabilities
Long-term operating … lease liabilities
Long-term deferred revenue
Deferred income taxes, net
Other long-term liabilities
Total liabilities
Total stockholders
8-K/A
EX-99.1
xvht4u2ulnpc4ejcmd
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
6hp76eiy
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
d8eq7
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
1dr8v
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
h4cjb sinvub70ahx7r
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
3cepw56g7nf54d lexh
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
h89lpgvtlo6f4 a1stn
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
S-3ASR
EX-1.2
g9lq7g8v0k
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
k5wvusfd
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm